Savara
SVRA
#6249
Rank
C$1.34 B
Marketcap
C$6.11
Share price
-18.23%
Change (1 day)
-11.94%
Change (1 year)

Earnings for Savara (SVRA)

Earnings in 2026 (TTM): -C$0.2 Billion

According to Savara's latest financial reports the company's current earnings are N/A. In 2025 the company made an earning of -C$0.18 Billion a decrease over its 2024 earnings that were of -C$0.14 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Savara from 2002 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -C$0.2 Billion14%
2025 -C$0.18 Billion23.94%
2024 -C$0.14 Billion75.29%
2023 -C$78.45 Million43.38%
2022 -C$54.72 Million-11.31%
2021 -C$61.69 Million-13.3%
2020 -C$71.16 Million-36.53%
2019 -C$0.12 Billion13.76%
2018 -C$98.55 Million105.54%
2017 -C$47.95 Million34.11%
2016 -C$35.76 Million-37.43%
2015 -C$57.14 Million38.81%
2014 -C$41.17 Million33.62%
2013 -C$30.81 Million38.49%
2012 -C$22.25 Million24.59%
2011 -C$17.86 Million-36.5%
2010 -C$28.12 Million-3.14%
2009 -C$29.03 Million-23.28%
2008 -C$37.84 Million8.52%
2007 -C$34.87 Million-34.14%
2006 -C$52.94 Million184.43%
2005 -C$18.62 Million90.75%
2004 -C$9.76 Million190.35%
2003 -C$3.37 Million11.64%
2002 -C$3.02 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
OPKO Health
OPK
-C$0.23 Billion 14.22%๐Ÿ‡บ๐Ÿ‡ธ USA
Onconova Therapeutics
ONTX
-C$26.04 Million-86.97%๐Ÿ‡บ๐Ÿ‡ธ USA